Be Biopharma, Inc. ("Be Bio" or "the Company"), a leader in the discovery and development of engineered B Cell ... FIX replacement regimens could address the considerable infusion burden associated ...

A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), ...

DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary ...

Health systems in Australia and globally face a series of unprecedented challenges that, unchecked, threaten our economic ...